JPRN-UMIN000010952已完成未知
Effects of linagliptin on diabetic nephropathy in CKD patients - Effects of linagliptin on diabetic nephropathy in CKD patients
Kurume University School of Medicine0 个研究点目标入组 60 人开始时间: 2013年6月13日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
There was no evidence of the benefit of torazenta.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) diabetic ketoacidosis 2) severe infection 3) pregnancy 4) CHF, AKI 5) severe liver dysfunction
研究者
相似试验
已完成
不适用
Efficacy of ipragliflozin on diabetic nephropathy in patients with type 2 diabetesType 2 diabetes with/without diabetic nephropathyJPRN-UMIN000022615Ogawa Red Cross Hospital50
已完成
4 期
The efficacy of teneligliptin in diabetic patients on hemodialysisType2 diabetic patients on hemodialysisJPRN-UMIN000010999Kawashima Hospital30
进行中（未招募）
不适用
Effects of Linagliptin on Renal Endothelium Function in Patients with Type 2 Diabetes.Diabetes mellitusEUCTR2012-002278-30-DEniversity Hospital Erlangen
已完成
不适用
Effect of topiroxostat on diabetic nephropathy in patients with type 2 diabetes mellitusJPRN-UMIN000038238Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University20
招募中
Unknown
The renal benefits of Tirzepatide for type 2 diabetes subjects with chronic kidney disease: prospective observational studyType 2 diabetesJPRN-UMIN000051442Kushiro Red Cross Hospital50